nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA6—ear—cleft lip	0.0225	0.0958	CbGeAlD
Imatinib—CA3—ear—cleft lip	0.0213	0.0907	CbGeAlD
Imatinib—CSF1R—periosteum—cleft lip	0.0209	0.0891	CbGeAlD
Imatinib—Nilotinib—EPHA3—cleft lip	0.014	0.32	CrCbGaD
Imatinib—Ponatinib—FGFR3—cleft lip	0.0115	0.263	CrCbGaD
Imatinib—CA2—periosteum—cleft lip	0.0113	0.0479	CbGeAlD
Imatinib—ABCA3—telencephalon—cleft lip	0.00939	0.04	CbGeAlD
Imatinib—CA6—mouth—cleft lip	0.0093	0.0396	CbGeAlD
Imatinib—Ponatinib—FGFR2—cleft lip	0.00909	0.208	CrCbGaD
Imatinib—Ponatinib—FGFR1—cleft lip	0.00909	0.208	CrCbGaD
Imatinib—CA3—mouth—cleft lip	0.00881	0.0375	CbGeAlD
Imatinib—DDR1—telencephalon—cleft lip	0.00866	0.0369	CbGeAlD
Imatinib—ABCA3—head—cleft lip	0.00585	0.0249	CbGeAlD
Imatinib—KIT—mouth—cleft lip	0.0054	0.023	CbGeAlD
Imatinib—PIP4K2C—telencephalon—cleft lip	0.00535	0.0228	CbGeAlD
Imatinib—CA3—telencephalon—cleft lip	0.00511	0.0217	CbGeAlD
Imatinib—PDGFRA—embryo—cleft lip	0.00482	0.0205	CbGeAlD
Imatinib—CA14—telencephalon—cleft lip	0.00464	0.0197	CbGeAlD
Imatinib—CSF1R—embryo—cleft lip	0.00424	0.0181	CbGeAlD
Imatinib—NQO2—telencephalon—cleft lip	0.00393	0.0167	CbGeAlD
Imatinib—PDGFRA—telencephalon—cleft lip	0.00392	0.0167	CbGeAlD
Imatinib—KIT—embryo—cleft lip	0.00385	0.0164	CbGeAlD
Imatinib—PDGFRB—embryo—cleft lip	0.00376	0.016	CbGeAlD
Imatinib—CA12—telencephalon—cleft lip	0.00362	0.0154	CbGeAlD
Imatinib—CSF1R—telencephalon—cleft lip	0.00345	0.0147	CbGeAlD
Imatinib—CA6—head—cleft lip	0.00336	0.0143	CbGeAlD
Imatinib—ABL1—embryo—cleft lip	0.00335	0.0143	CbGeAlD
Imatinib—PIP4K2C—head—cleft lip	0.00333	0.0142	CbGeAlD
Imatinib—CA2—mouth—cleft lip	0.0032	0.0136	CbGeAlD
Imatinib—CA3—head—cleft lip	0.00318	0.0135	CbGeAlD
Imatinib—KIT—telencephalon—cleft lip	0.00313	0.0133	CbGeAlD
Imatinib—PDGFRB—telencephalon—cleft lip	0.00306	0.013	CbGeAlD
Imatinib—CA1—telencephalon—cleft lip	0.00286	0.0122	CbGeAlD
Imatinib—ABL1—telencephalon—cleft lip	0.00273	0.0116	CbGeAlD
Imatinib—SLC22A1—telencephalon—cleft lip	0.00263	0.0112	CbGeAlD
Imatinib—NQO2—head—cleft lip	0.00245	0.0104	CbGeAlD
Imatinib—PDGFRA—head—cleft lip	0.00244	0.0104	CbGeAlD
Imatinib—CA2—embryo—cleft lip	0.00228	0.00972	CbGeAlD
Imatinib—CA12—head—cleft lip	0.00225	0.00959	CbGeAlD
Imatinib—CSF1R—head—cleft lip	0.00215	0.00915	CbGeAlD
Imatinib—SLC47A1—head—cleft lip	0.00196	0.00835	CbGeAlD
Imatinib—KIT—head—cleft lip	0.00195	0.00831	CbGeAlD
Imatinib—PDGFRB—head—cleft lip	0.0019	0.00811	CbGeAlD
Imatinib—CA2—telencephalon—cleft lip	0.00186	0.00791	CbGeAlD
Imatinib—CA1—head—cleft lip	0.00178	0.0076	CbGeAlD
Imatinib—ABCG2—telencephalon—cleft lip	0.00172	0.00732	CbGeAlD
Imatinib—ABL1—head—cleft lip	0.0017	0.00723	CbGeAlD
Imatinib—SLC22A1—head—cleft lip	0.00164	0.00697	CbGeAlD
Imatinib—PTGS1—telencephalon—cleft lip	0.00143	0.00611	CbGeAlD
Imatinib—CYP2D6—telencephalon—cleft lip	0.00118	0.00502	CbGeAlD
Imatinib—CA2—head—cleft lip	0.00116	0.00492	CbGeAlD
Imatinib—ABCB1—embryo—cleft lip	0.00104	0.00444	CbGeAlD
Imatinib—PTGS1—head—cleft lip	0.000893	0.0038	CbGeAlD
Imatinib—ABCB1—telencephalon—cleft lip	0.000848	0.00361	CbGeAlD
Imatinib—CYP2D6—head—cleft lip	0.000734	0.00313	CbGeAlD
Imatinib—ABCB1—head—cleft lip	0.000528	0.00225	CbGeAlD
Imatinib—PDGFRB—Innate Immune System—FGFR1—cleft lip	0.000111	0.000154	CbGpPWpGaD
Imatinib—KIT—Disease—FGF9—cleft lip	0.000111	0.000154	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—WNT3—cleft lip	0.00011	0.000153	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF3—cleft lip	0.000109	0.000151	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FGFR1—cleft lip	0.000109	0.000151	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TCN2—cleft lip	0.000109	0.00015	CbGpPWpGaD
Imatinib—CA2—Metabolism—TYMS—cleft lip	0.000108	0.00015	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF3—cleft lip	0.000108	0.00015	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TCN2—cleft lip	0.000108	0.000149	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TCN2—cleft lip	0.000107	0.000149	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—FGFR1—cleft lip	0.000107	0.000148	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SPRY2—cleft lip	0.000106	0.000148	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF7—cleft lip	0.000106	0.000148	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF9—cleft lip	0.000106	0.000148	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF3—cleft lip	0.000106	0.000146	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF9—cleft lip	0.000105	0.000146	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—FGFR3—cleft lip	0.000105	0.000146	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TCN2—cleft lip	0.000104	0.000145	CbGpPWpGaD
Imatinib—LCK—Disease—SPRY2—cleft lip	0.000104	0.000144	CbGpPWpGaD
Imatinib—LCK—Disease—FGF7—cleft lip	0.000104	0.000144	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF8—cleft lip	0.000104	0.000144	CbGpPWpGaD
Imatinib—CA1—Metabolism—TYMS—cleft lip	0.000104	0.000144	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF9—cleft lip	0.000103	0.000143	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF3—cleft lip	0.000103	0.000143	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FGFR3—cleft lip	0.000103	0.000142	CbGpPWpGaD
Imatinib—CA14—Metabolism—NOS3—cleft lip	0.000102	0.000142	CbGpPWpGaD
Imatinib—KIT—Immune System—FGF10—cleft lip	0.000102	0.000141	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—FGFR3—cleft lip	0.000101	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SPRY2—cleft lip	0.000101	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF7—cleft lip	0.000101	0.00014	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF9—cleft lip	0.0001	0.000139	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TCN2—cleft lip	0.0001	0.000139	CbGpPWpGaD
Imatinib—CA6—Metabolism—NOS3—cleft lip	9.98e-05	0.000138	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF8—cleft lip	9.83e-05	0.000136	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF3—cleft lip	9.74e-05	0.000135	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGF10—cleft lip	9.63e-05	0.000133	CbGpPWpGaD
Imatinib—LCK—Disease—FGF8—cleft lip	9.6e-05	0.000133	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGFR2—cleft lip	9.6e-05	0.000133	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—FGF2—cleft lip	9.54e-05	0.000132	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF9—cleft lip	9.5e-05	0.000132	CbGpPWpGaD
Imatinib—CA2—Metabolism—MTHFR—cleft lip	9.46e-05	0.000131	CbGpPWpGaD
Imatinib—KIT—Disease—FGF10—cleft lip	9.4e-05	0.00013	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC19A1—cleft lip	9.39e-05	0.00013	CbGpPWpGaD
Imatinib—CA7—Metabolism—NOS3—cleft lip	9.32e-05	0.000129	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF8—cleft lip	9.3e-05	0.000129	CbGpPWpGaD
Imatinib—LCK—Disease—MTR—cleft lip	9.28e-05	0.000129	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGFR2—cleft lip	9.21e-05	0.000128	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—FGF2—cleft lip	9.17e-05	0.000127	CbGpPWpGaD
Imatinib—CA9—Metabolism—TYMS—cleft lip	9.13e-05	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SPRY2—cleft lip	9.08e-05	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF7—cleft lip	9.08e-05	0.000126	CbGpPWpGaD
Imatinib—CA1—Metabolism—MTHFR—cleft lip	9.07e-05	0.000126	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—FGF2—cleft lip	9.03e-05	0.000125	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—FGF2—cleft lip	8.98e-05	0.000124	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF10—cleft lip	8.98e-05	0.000124	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGFR1—cleft lip	8.94e-05	0.000124	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF10—cleft lip	8.89e-05	0.000123	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PTCH1—cleft lip	8.82e-05	0.000122	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—NOS3—cleft lip	8.69e-05	0.00012	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF10—cleft lip	8.68e-05	0.00012	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—FGF2—cleft lip	8.68e-05	0.00012	CbGpPWpGaD
Imatinib—CA12—Metabolism—NOS3—cleft lip	8.63e-05	0.00012	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGFR1—cleft lip	8.59e-05	0.000119	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF3—cleft lip	8.47e-05	0.000117	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF10—cleft lip	8.46e-05	0.000117	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGFR3—cleft lip	8.45e-05	0.000117	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF8—cleft lip	8.38e-05	0.000116	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PTCH1—cleft lip	8.35e-05	0.000116	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	8.29e-05	0.000115	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF9—cleft lip	8.26e-05	0.000114	CbGpPWpGaD
Imatinib—KIT—Immune System—FGFR2—cleft lip	8.17e-05	0.000113	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—FGF2—cleft lip	8.14e-05	0.000113	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGFR3—cleft lip	8.12e-05	0.000112	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC19A1—cleft lip	8.09e-05	0.000112	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF10—cleft lip	8.01e-05	0.000111	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF3—cleft lip	8e-05	0.000111	CbGpPWpGaD
Imatinib—CA9—Metabolism—MTHFR—cleft lip	7.97e-05	0.00011	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FGF2—cleft lip	7.93e-05	0.00011	CbGpPWpGaD
Imatinib—LCK—Disease—FGF3—cleft lip	7.82e-05	0.000108	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—FGF2—cleft lip	7.82e-05	0.000108	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF9—cleft lip	7.8e-05	0.000108	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TCN2—cleft lip	7.78e-05	0.000108	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGFR2—cleft lip	7.73e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Disease—FGF9—cleft lip	7.62e-05	0.000106	CbGpPWpGaD
Imatinib—KIT—Immune System—FGFR1—cleft lip	7.61e-05	0.000105	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF3—cleft lip	7.57e-05	0.000105	CbGpPWpGaD
Imatinib—KIT—Disease—FGFR2—cleft lip	7.54e-05	0.000104	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTR—cleft lip	7.53e-05	0.000104	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PTCH1—cleft lip	7.53e-05	0.000104	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTR—cleft lip	7.46e-05	0.000103	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTR—cleft lip	7.45e-05	0.000103	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF9—cleft lip	7.38e-05	0.000102	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SPRY2—cleft lip	7.29e-05	0.000101	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF7—cleft lip	7.29e-05	0.000101	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC19A1—cleft lip	7.26e-05	0.000101	CbGpPWpGaD
Imatinib—KIT—Disease—MTHFR—cleft lip	7.26e-05	0.000101	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTR—cleft lip	7.23e-05	0.0001	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGFR2—cleft lip	7.21e-05	9.99e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGFR1—cleft lip	7.2e-05	9.98e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—FGFR3—cleft lip	7.19e-05	9.97e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—NOS3—cleft lip	7.16e-05	9.92e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGFR2—cleft lip	7.14e-05	9.89e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC19A1—cleft lip	7.08e-05	9.82e-05	CbGpPWpGaD
Imatinib—KIT—Disease—FGFR1—cleft lip	7.03e-05	9.74e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGFR2—cleft lip	6.96e-05	9.65e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF10—cleft lip	6.96e-05	9.65e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTR—cleft lip	6.94e-05	9.62e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—MTHFR—cleft lip	6.87e-05	9.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF3—cleft lip	6.82e-05	9.45e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGFR3—cleft lip	6.81e-05	9.44e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGFR2—cleft lip	6.79e-05	9.4e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF8—cleft lip	6.73e-05	9.32e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGFR1—cleft lip	6.72e-05	9.31e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—TCN2—cleft lip	6.7e-05	9.28e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC19A1—cleft lip	6.68e-05	9.25e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGFR1—cleft lip	6.65e-05	9.22e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF9—cleft lip	6.65e-05	9.22e-05	CbGpPWpGaD
Imatinib—KIT—Disease—FGFR3—cleft lip	6.64e-05	9.2e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC19A1—cleft lip	6.62e-05	9.17e-05	CbGpPWpGaD
Imatinib—CA2—Metabolism—NOS3—cleft lip	6.6e-05	9.14e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF10—cleft lip	6.58e-05	9.12e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGF2—cleft lip	6.53e-05	9.05e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGFR1—cleft lip	6.49e-05	9e-05	CbGpPWpGaD
Imatinib—LCK—Disease—FGF10—cleft lip	6.43e-05	8.91e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGFR2—cleft lip	6.43e-05	8.91e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGFR3—cleft lip	6.35e-05	8.8e-05	CbGpPWpGaD
Imatinib—CA1—Metabolism—NOS3—cleft lip	6.33e-05	8.77e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGFR1—cleft lip	6.33e-05	8.77e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGFR3—cleft lip	6.29e-05	8.71e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGF2—cleft lip	6.27e-05	8.69e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF10—cleft lip	6.23e-05	8.63e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—MTHFR—cleft lip	6.19e-05	8.58e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGFR3—cleft lip	6.13e-05	8.5e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTCH1—cleft lip	6.04e-05	8.37e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TCN2—cleft lip	6.01e-05	8.33e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGFR1—cleft lip	5.99e-05	8.3e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGFR3—cleft lip	5.98e-05	8.28e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TCN2—cleft lip	5.87e-05	8.13e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGFR3—cleft lip	5.66e-05	7.85e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC19A1—cleft lip	5.66e-05	7.84e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF10—cleft lip	5.61e-05	7.78e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—FGFR2—cleft lip	5.59e-05	7.74e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—NOS3—cleft lip	5.56e-05	7.71e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—FGF2—cleft lip	5.56e-05	7.7e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TCN2—cleft lip	5.53e-05	7.67e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TCN2—cleft lip	5.48e-05	7.6e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF3—cleft lip	5.48e-05	7.59e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	5.42e-05	7.51e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTR—cleft lip	5.39e-05	7.47e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF9—cleft lip	5.34e-05	7.4e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGFR2—cleft lip	5.28e-05	7.32e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGF2—cleft lip	5.26e-05	7.29e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—FGFR1—cleft lip	5.21e-05	7.22e-05	CbGpPWpGaD
Imatinib—LCK—Disease—FGFR2—cleft lip	5.16e-05	7.15e-05	CbGpPWpGaD
Imatinib—KIT—Disease—FGF2—cleft lip	5.13e-05	7.11e-05	CbGpPWpGaD
Imatinib—KIT—Disease—NOS3—cleft lip	5.06e-05	7.01e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGFR2—cleft lip	5e-05	6.93e-05	CbGpPWpGaD
Imatinib—LCK—Disease—MTHFR—cleft lip	4.97e-05	6.88e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—FGFR3—cleft lip	4.92e-05	6.82e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGFR1—cleft lip	4.92e-05	6.82e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF2—cleft lip	4.91e-05	6.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF2—cleft lip	4.86e-05	6.73e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NOS3—cleft lip	4.84e-05	6.7e-05	CbGpPWpGaD
Imatinib—LCK—Disease—FGFR1—cleft lip	4.81e-05	6.66e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS3—cleft lip	4.79e-05	6.64e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF2—cleft lip	4.74e-05	6.57e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TCN2—cleft lip	4.69e-05	6.49e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGFR1—cleft lip	4.66e-05	6.46e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGFR3—cleft lip	4.65e-05	6.45e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTR—cleft lip	4.64e-05	6.44e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF2—cleft lip	4.62e-05	6.4e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TYMS—cleft lip	4.61e-05	6.39e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TYMS—cleft lip	4.57e-05	6.34e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TYMS—cleft lip	4.57e-05	6.33e-05	CbGpPWpGaD
Imatinib—LCK—Disease—FGFR3—cleft lip	4.55e-05	6.3e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGFR2—cleft lip	4.5e-05	6.24e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF10—cleft lip	4.5e-05	6.24e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TYMS—cleft lip	4.43e-05	6.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGFR3—cleft lip	4.4e-05	6.1e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF2—cleft lip	4.38e-05	6.07e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC19A1—cleft lip	4.36e-05	6.05e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS3—cleft lip	4.32e-05	5.98e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS3—cleft lip	4.28e-05	5.93e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TYMS—cleft lip	4.25e-05	5.9e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGFR1—cleft lip	4.2e-05	5.82e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTR—cleft lip	4.17e-05	5.78e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTR—cleft lip	4.07e-05	5.64e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—cleft lip	4.03e-05	5.58e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—cleft lip	3.99e-05	5.53e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—cleft lip	3.99e-05	5.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGFR3—cleft lip	3.97e-05	5.5e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—cleft lip	3.87e-05	5.37e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTR—cleft lip	3.83e-05	5.31e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF2—cleft lip	3.8e-05	5.27e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTR—cleft lip	3.8e-05	5.27e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—cleft lip	3.72e-05	5.15e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TCN2—cleft lip	3.62e-05	5.01e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGFR2—cleft lip	3.61e-05	5.01e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF2—cleft lip	3.59e-05	4.98e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOS3—cleft lip	3.54e-05	4.91e-05	CbGpPWpGaD
Imatinib—LCK—Disease—FGF2—cleft lip	3.51e-05	4.87e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS3—cleft lip	3.46e-05	4.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF2—cleft lip	3.4e-05	4.71e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGFR1—cleft lip	3.37e-05	4.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOS3—cleft lip	3.36e-05	4.65e-05	CbGpPWpGaD
Imatinib—KIT—Disease—MYC—cleft lip	3.36e-05	4.65e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TYMS—cleft lip	3.31e-05	4.58e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTR—cleft lip	3.25e-05	4.5e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MYC—cleft lip	3.21e-05	4.44e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGFR3—cleft lip	3.18e-05	4.41e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—MYC—cleft lip	3.18e-05	4.4e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF2—cleft lip	3.07e-05	4.25e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOS3—cleft lip	3.02e-05	4.19e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—cleft lip	2.89e-05	4e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—MYC—cleft lip	2.86e-05	3.97e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—TYMS—cleft lip	2.85e-05	3.94e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NOS3—cleft lip	2.81e-05	3.89e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NOS3—cleft lip	2.79e-05	3.86e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NOS3—cleft lip	2.78e-05	3.85e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NOS3—cleft lip	2.7e-05	3.74e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—cleft lip	2.59e-05	3.59e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TYMS—cleft lip	2.56e-05	3.54e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTR—cleft lip	2.51e-05	3.47e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TYMS—cleft lip	2.49e-05	3.46e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—cleft lip	2.49e-05	3.45e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF2—cleft lip	2.46e-05	3.41e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—cleft lip	2.43e-05	3.36e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TYMS—cleft lip	2.35e-05	3.26e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MYC—cleft lip	2.35e-05	3.26e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TYMS—cleft lip	2.33e-05	3.23e-05	CbGpPWpGaD
Imatinib—LCK—Disease—MYC—cleft lip	2.3e-05	3.18e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—cleft lip	2.23e-05	3.09e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MYC—cleft lip	2.22e-05	3.08e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—cleft lip	2.18e-05	3.02e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—cleft lip	2.05e-05	2.85e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—cleft lip	2.04e-05	2.82e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—cleft lip	2.01e-05	2.79e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MYC—cleft lip	2e-05	2.78e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TYMS—cleft lip	1.99e-05	2.76e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—cleft lip	1.74e-05	2.41e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—cleft lip	1.73e-05	2.4e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MYC—cleft lip	1.61e-05	2.23e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—cleft lip	1.56e-05	2.16e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TYMS—cleft lip	1.54e-05	2.13e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—cleft lip	1.52e-05	2.11e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—cleft lip	1.43e-05	1.98e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—cleft lip	1.42e-05	1.97e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—cleft lip	1.34e-05	1.86e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—cleft lip	1.21e-05	1.68e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—cleft lip	9.36e-06	1.3e-05	CbGpPWpGaD
